SCHEMBL4378460

SCHEMBL4378460

CCCCC(O)CC(O)CCCC

nearest known ligand 0.44

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 6/20 0.44
FFAR4 Q5NUL3 1/20 0.43
FFAR1 O14842 1/20 0.43
ALDH1A1 P00352 1/20 0.42
NFKB1 P19838 1/20 0.41
DNM1 Q05193 2/20 0.41
FDPS P14324 1/20 0.40
CA2 P00918 1/20 0.39
MAPK1 P28482 1/20 0.39
PSMD14 O00487 2/20 0.38
PLA2G1B P04054 2/20 0.38
MMP2 P08253 2/20 0.38
ATG4B Q9Y4P1 2/20 0.38
HSP90AA1 P07900 1/20 0.38
RAD52 P43351 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14533072 1.00 GPR84 (0.44) GPR84FFAR4FFAR1ALDH1A1NFKB1
SCHEMBL14533070 1.00 GPR84 (0.44) GPR84FFAR4FFAR1ALDH1A1NFKB1
SCHEMBL28575324 0.94 GPR84 (0.41) GPR84FFAR4FFAR1ALDH1A1NFKB1
SCHEMBL6281896 0.94 GPR84 (0.41) GPR84FFAR4FFAR1ALDH1A1NFKB1
SCHEMBL5617508 0.94 GPR84 (0.52) GPR84FFAR4FFAR1NFKB1DNM1
SCHEMBL15247077 0.92 GPR84 (0.40) GPR84FFAR4FFAR1ALDH1A1NFKB1
SCHEMBL30787488 0.92 GPR84 (0.56) GPR84FFAR4FFAR1NFKB1DNM1
SCHEMBL30787199 0.92 GPR84 (0.56) GPR84FFAR4FFAR1NFKB1DNM1
SCHEMBL13041137 0.92 ALDH1A1 (0.42) GPR84FFAR4FFAR1ALDH1A1NFKB1
SCHEMBL30787289 0.92 GPR84 (0.56) GPR84FFAR4FFAR1NFKB1DNM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008055964-A1 METHOD FOR PRODUCING CYCLIC PHOSPHINES OR BIPHOSPHINES, CYCLIC PHOSPHONATES OF OPTICALLY ACTIVE DIOLS, AND THE PRODUCTION OF SAME Rheinisch-Westfälische Technische Hochschule Aachen (DE) 2008-05-15 WO claimed
EP-4554379-A1 USE OF AN ALKANEDIOL AS HERBICIDE Apeo - Agronomical Plant Extracts & Essential Oils (BE) 2025-05-21 EP disclosed
WO-2024013148-A1 USE OF AN ALKANEDIOL AS HERBICIDE APEO – AGRONOMICAL PLANT EXTRACTS & ESSENTIAL OILS (BE) 2024-01-18 WO disclosed
US-7534547-B2 Optically active compound and photosensitive resin composition OSAKA GAS COMPANY LIMITED (JP) 2009-05-19 US disclosed
WO-2008055963-A1 NOVEL METHOD FOR PRODUCING ORGANIC PHOSPHORUS COMPOUNDS, PHOSPHORUS COMPOUNDS PRODUCED USING SAID METHOD, THE METAL COMPLEXES OF SAID COMPOUNDS, AND USE OF SAME Rheinisch-Westfälische Technische Hochschule Aachen (DE) 2008-05-15 WO disclosed
WO-2008055964-A1 METHOD FOR PRODUCING CYCLIC PHOSPHINES OR BIPHOSPHINES, CYCLIC PHOSPHONATES OF OPTICALLY ACTIVE DIOLS, AND THE PRODUCTION OF SAME Rheinisch-Westfälische Technische Hochschule Aachen (DE) 2008-05-15 WO disclosed
JP-2004194540-A METHOD FOR PRODUCING AROMATIC ALDEHYDE COMPOUND MITSUBISHI CHEMICALS CORP 2004-07-15 JP disclosed
EP-1375463-A1 OPTICALLY ACTIVE COMPOUND AND PHOTOSENSITIVE RESIN COMPOSITION Kansai Research Institute, Inc. (JP) 2004-01-02 EP disclosed
US-20030211421-A1 Optically active compound and photosensitive resin composition KRI, INC. (JP) 2003-11-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030211421-A1 Optically active compound and photosensitive resin composition ARCN1, RAD51, PAM GPR84 1217/4885FFAR4 2882/4885FFAR1 1120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.